Waiting
로그인 처리 중...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / Induction of Invasive Transitional Cell Bladder…
JoVE Journal
Medicine

JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다. 전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.

JoVE Journal Medicine
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice
 

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Article DOI: 10.3791/50868-v • 11:02 min • October 30th, 2013
October 30th, 2013 •
1, 1, 2, 1, 1, 1, 3, 1
1Department of Internal Medicine, Division of Hematology and Oncology, University of California, Davis, 2Comparative Pathology Laboratory, UC Davis School of Veterinary Medicine, University of California, Davis, 3Merck Serono Research, Merck KGaA, Darmstadt, Germany

챕터

요약
Automatic Translation

An N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder cancer model was developed in human mucin 1 (MUC1) transgenic mice for the purpose of testing MUC1-directed immunotherapy. After administering a MUC1-targeted peptide vaccine, a cytotoxic T lymphocyte response to MUC1 was confirmed by measuring serum cytokine levels and T-cell specific activity.

Tags

Invasive Transitional Cell Bladder Carcinoma MUC1 Transgenic Mice Immunotherapy Development Preclinical Model Bladder Cancer Mucin 1 OH-BBN Carcinogen Serum Cytokine Profile MUC1-targeted Peptide Vaccine Placebo Multiplex Fluorometric Microbead Immunoanalyses Interferon Gamma Interleukin-4 ELISpot Analysis T-cell Immune Response Histopathological Evaluations Tumor Type And Grade
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter